3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
12
Ovarian Neoplasms
11
Fallopian Tube Neoplasms
10
Carcinoma, Non-Small-Cell Lung
7
Pancreatic Neoplasms
5
Brenner Tumor
5
Lung Neoplasms
4
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Carcinoma
3
Adenocarcinoma of Lung
3
Oropharyngeal Neoplasms
2
Neurotoxicity Syndromes
2
Mouth Neoplasms
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Carcinosarcoma
2
Carcinoma, Transitional Cell
2
Vomiting
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Recurrent Uterine Corpus Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Cancer Resectable
1
Pancreatic Adenocarcinoma
1
Pancreas Adenocarcinoma
1
Pain
1
Ovarian Germ Cell Cancer
1
Interventions
Dexamethasone
23
Ondansetron
12
Palonosetron
11
Aprepitant
9
Granisetron
7
Olanzapine
5
ramosetron
3
netupitant, palosentron drug combination
3
casopitant
3
Radiotherapy
3
fosaprepitant
2
Thalidomide
2
Prochlorperazine
2
Electroacupuncture
2
Dronabinol
2
Analgesia
2
Acupressure
2
sinomenine
1
netupitant
1
lerisetron
1
dolasetron
1
dexamethasone acetate
1
Tropisetron
1
Therapeutics
1
Taxes
1
Tablets
1
Surveys and Questionnaires
1
Sugars
1
Metoclopramide
1
Hygiene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Vomiting
×
Taxes
×
Clear all
NCT06017284
2023-11-24
PTCA199-5
Fudan University
Phase 3
Recruiting
100 enrolled